ESC Premium Access

Pulmonary hypertension: progress in management, impact on outcomes

Event: ESC Congress 2018
Topic: Epidemiology, Prognosis, Outcome
Session type: Rapid Fire Abstracts
Date: 27 August 2018
Time: 08:30 - 10:00


10 presentations in this session

Fast screening breath analysis for diagnostics of pulmonary hypertension.

Speaker: Assistant Professor A. Swinarew (Katowice, PL)

Phenomapping to detect non-invasively patients with combined postcapillary pulmonary hypertension

Speaker: Doctor O. Raitiere (Rouen, FR)

Impact of comorbidity on outcome in CTD-associated pulmonary arterial hypertension: data from the Swedish Pulmonary Arterial Hypertension Registry

Speaker: Doctor C. Hjalmarsson (Gothenburg, SE)

Long-term survival and safety with selexipag in patients with pulmonary arterial hypertension: results from the GRIPHON study and its open-label extension

Speaker: Professor N. Galie (Bologna, IT)

Improved ten-year survival of systemic sclerosis-associated pulmonary arterial hypertension in the contemporary treatment era: a single centre retrospective study of 451 patients.

Speaker: Doctor H. Fayed (London, GB)

Comparison between paediatric and adult patients with pulmonary arterial hypertension

Speaker: Doctor E. Zuffa (Bologna, IT)

The emPHasis-10 quality of life score for pulmonary hypertension is a strong predictor of mortality

Speaker: Doctor C. Favoccia (London, GB)

Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study)

Speaker: Doctor A. Marra (Naples, IT)

Effects of combined angiotensin II receptor antagonism and neprilysin inhibition in pulmonary arterial hypertension and right heart failure

Speaker: Miss S. Andersen (Aarhus, DK)

Relative bioavailability and pharmacokinetic (PK) performance of a ralinepag extended-release (XR) tablet oral formulation and the effect of food and gender in healthy human subjects

Speaker: Doctor J. Adams (San Diego, US)

10 speakers from this session

Assistant Professor Andrzej Swinarew

University of Silesia, Katowice (Poland)
0 follower

Doctor Olivier Raitiere

University Hospital of Rouen, Rouen (France)
0 follower

Doctor Clara Hjalmarsson

Sahlgrenska University Hospital, Department of Internal Medicine, Gothenburg (Sweden)
0 follower

Professor Nazzareno Galie

Alma Mater Studiorum, University of Bologna, Bologna (Italy)
14 presentations
0 follower

Doctor Hossam Fayed

University College London, London (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

Doctor Elisa Zuffa

S. Orsola-Malpighi Policlinic, Bologna (Italy)
0 follower

Doctor Carla Favoccia

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Alberto Maria Marra

Federico II University Hospital, Naples (Italy)
0 follower

Miss Stine Andersen

Aarhus University Hospital, Skejby, Department of Cardiology & Institute of Clinical Medicine, Aarhus (Denmark)
0 follower

Doctor John Adams

Arena, San Diego (United States of America)
0 follower

This platform is supported by

logo Novo Nordisk